Wednesday’s Top Biotech & Medical Stocks
by H.S. AyoubBioHealth Investor.com
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 373Dendreon’s New ‘Hold’ Rating at A.G.Edwards
A.G.Edwards has initiated the recently volatile and controversial Dendreon (DNDN-NASDAQ) with a Hold/Speculative rating. The summary points are that it is starting the biotech as a Hold rated stock for Speculative investors. It sees…
Cramer’s Obesity Stock Plays
Jim Cramer has a video on TheStreet.com this morning discussing obesity stock plays. With 7 million Americans more than 100 pounds overweight and $33 Billion is spent on healthcare per year on obesity alone. …
Tuesday’s Top Biotech & Medical Stocks
by H.S. AyoubBioHealth Investor.com
Bruker’s Profits Increase, So Why the 20% Drop?
by H.S. AyoubBioHealth Investor.com
Monday’s Top Biotech & Medical Stocks
by H.S. AyoubBioHealth Investor.com
Cramer Goes to Baxter (BAX)
Jim Cramer’s third pick as a defensive medical industrial complex stock that he thinks can’t get hurt by the economy is Baxter International (BAX), but he would only buy it if it pulls back…
Cramer Backs Becton Dickinson (BDX)
Jim Cramer’s Second defensive stock on CNBC’s MAD MONEY in medical devices as a portfolio of last resort is Becton Dickinson (BDX). It is a safe traditional medical device and diagnostics company. They even…
Friday’s Top Biotech & Medical Stocks
by H.S. AyoubBioHealth Investor.com
IBD Weekly Top Ranked Medical Stocks
From BioHealth Investor
Dendreon: Countdown to FDA (DNDN)
Dendreon’s short interest actually grew again in April from 26.4 million shares in March to 33.9 million shares. The short interest was listed as 16.8 million shares in February. That is almost infathomable if…
Thursday’s Top Biotech & Medical Stocks
Biotechnology INNOVIVE PHARMACEUTL +12.99% NEURALSTEM INC +12.53% ADVANCED LIFE SCIENC +9.52% LPATH INC +9.29% VANDA PHARMACEUTICAL +7.89% Diagnostic Substances TRINITY BIO ADR +9.31% PRESSURE BIOSCIENC +9.01% SYNOVICS PHARMACEUTL +6.67% DIGENE CP +6.35% ROSETTA GENOMICS…
FRX – Forest Laboratories: Lexapro Maintains Market Share in Antidepressant Drug Market
We do not consider the reported loss for Q4 to be meaningful. This was expected; the charges relate to the acquisition of Cerexa. In January 2007, FRX acquired Cerexa for $494M in cash plus…
Tuesday’s Top Biotech & Medical Stocks
by H.S. AyoubBioHealth Investor.com
Wal-Mart General Hospital
Wal-Mart Stores, Inc. (WMT-NYSE), has announced that it intends to contract with local hospitals to open as many as 400 in-store health clinics over the next two to three years. For future growth it…